Celecoxib (Celebrex)

DRUG7 trials

Sponsors

Seattle Institute for Biomedical and Clinical Research, National Eye Institute (NEI), M.D. Anderson Cancer Center, National Taiwan University Hospital, University of Delaware

Conditions

Alzheimer DiseaseAnaplastic Glioma of BrainBrain CancerGlioblastoma MultiformeHypertensionMacular DegenerationNeurofibromatosis 1Osteoarthritis

Phase 2

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

CompletedNCT00504660

M.D. Anderson Cancer CenterAnaplastic Glioma of Brain, Brain Cancer, Glioblastoma Multiforme

Start: 2003-09-30End: 2010-08-31Updated: 2012-01-11

Medical Treatment of High-Risk Neurofibromas

CompletedNCT00846430

Corewell Health WestNeurofibromatosis 1

Start: 2008-10-31End: 2017-05-31Updated: 2023-08-30

Triple Negative Breast Cancer and Celecoxib. Pilot Study

RecruitingNCT07104266

Université de SherbrookeTriple-Negative Breast Cancer

Start: 2025-08-04End: 2032-08-04Target: 30Updated: 2025-08-05

Phase 3

Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

CompletedNCT00007189

Seattle Institute for Biomedical and Clinical ResearchAlzheimer Disease

Start: 2001-01-31Target: 2625Updated: 2016-10-19

Laser and Medical Treatment of Diabetic Macular Edema

CompletedNCT00050479

National Eye Institute (NEI)Macular Degeneration

Start: 2002-12-31End: 2006-07-31Target: 100Updated: 2006-07-19

Phase 4

Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty

CompletedNCT00598234

National Taiwan University HospitalOsteoarthritis

Start: 2006-09-30End: 2009-08-31Target: 120Updated: 2010-06-22

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

CompletedNCT00624559

University of DelawareHypertension

Start: 2008-02-29End: 2009-01-31Updated: 2012-01-06

Related Papers

Perioperative celecoxib administration for pain management after total knee arthroplasty - a randomized, controlled study.

2008-06-0396 citations